Home
Conditions
Sezary Syndrome

Clinical trial condition

Sezary Syndrome

Explore clinical trials studying Sezary Syndrome. Study availability and eligibility vary by location and protocol.

262 public trials 17 recruiting studies

Refine in advanced search Browse all conditions

Sezary Syndrome trial results

Completed

O6-Benzylguanine and Topical Carmustine in Treating Patients With Early-Stage IA-IIA Cutaneous T-Cell Lymphoma

NCT00961220

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +13 more
Locations: Henry Ford Hospital Detroit, Michigan, United States

Case Comprehensive Cancer Center Cleveland, Ohio, United States

Case Western Reserve University Cleveland, Ohio, United States

Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Completed

Alisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma, or Peripheral T-Cell Lymphoma

NCT01567709

Conditions: Adult B Acute Lymphoblastic Leukemia, Adult T Acute Lymphoblastic Leukemia, Anaplastic Large Cell Lymphoma, +84 more
Locations: City of Hope Comprehensive Cancer Center Duarte, California, United States

USC / Norris Comprehensive Cancer Center Los Angeles, California, United States

University of California Davis Comprehensive Cancer Center Sacramento, California, United States

Penn State Milton S Hershey Medical Center Hershey, Pennsylvania, United States

View Trial Details

Completed

Natural History Study of Fungal Infections of the Blood in Patients With Cancer or in Patients Who Have Undergone a Stem Cell Transplant

NCT00445952

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +116 more
Locations: Institut Jules Bordet Brussels, Belgium

CHU de Grenoble - Hopital de la Tronche Grenoble, France

German Hodgkin's Lymphoma Study Group Cologne, Germany

Ospedale San Martino Genoa, Italy

View Trial Details

Completed

Flu Vaccine in Preventing Influenza Infection in Healthy Volunteers and in Patients Who Have Undergone Stem Cell Transplant

NCT00964821

Conditions: Anemia, Anemia, Aplastic, Blast Crisis, +73 more
Locations: City of Hope Comprehensive Cancer Center Duarte, California, United States

City of Hope Medical Group Pasadena, California, United States

View Trial Details

Completed

Low-Dose Fludarabine, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer

NCT00301951

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +55 more
Locations: UCSF Comprehensive Cancer Center San Francisco, California, United States

View Trial Details

Completed

Lenalidomide After Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancers

NCT01254578

Conditions: Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11, Adult Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1, +96 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Completed

Allogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based Regimen

NCT00448357

Conditions: Blast Crisis, Blood Coagulation Disorders, Blood Platelet Disorders, +72 more
Locations: Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States

View Trial Details

Completed

Gemcitabine Hydrochloride, Carboplatin, Dexamethasone, and Rituximab in Treating Patients With Previously Treated Lymphoid Malignancies

NCT00072514

Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +80 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease

NCT00448201

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +66 more
Locations: Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States

View Trial Details

Completed

Music in Reducing Anxiety and Pain in Adult Patients Undergoing Bone Marrow Biopsy for Hematologic Cancers or Other Diseases

NCT00376922

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +101 more
Locations: Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States

View Trial Details

Sezary Syndrome

Sezary Syndrome trial results

Related conditions